NEWSROOM
Press Releases by Agendia
News
Press Releases
Agendia Names Industry Veteran Glen Fredenberg CFO and Vice President of Finance
IRVINE, CA and AMSTERDAM, THE NETHERLANDS, July 9, 2012 – Agendia, an innovative molecular cancer diagnostics company and leader in personalized medicine, today announced a key addition to their executive team with the appointment of Read More
Agendia Announces Launch of ColoPrint for Colon Cancer Prognosis and Prediction
Agendia’s Microarray-based Gene Expression Profile Provides Critical Additional Information for Treatment Decisions for Stage II Colon Cancer Patients IRVINE, CA and AMSTERDAM, THE NETHERLANDS, June 1, 2012 – Agendia, an innovative molecular cancer diagnostics company Read More
Agendia Raises $65 Million in a Private Round of Equity Financing
IRVINE, CA and AMSTERDAM, THE NETHERLANDS, May 31, 2012 – Agendia, an innovative molecular cancer diagnostics company and leader in personalized medicine, today announced that the company has raised USD $65 million in a private Read More
Agendia Announces Nine Studies in Breast and Colon Cancer for Presentation at 2012 Annual Meeting of the American Society of Clinical Oncology (ASCO)
AMSTERDAM, THE NETHERLANDS, and IRVINE, CA, May 29, 2012 – Agendia, an innovative molecular cancer diagnostics company and leader in personalized medicine, announced today that it will present nine posters on genomic research studies in Read More
RASTER: First-Ever Prospective Diagnostic Study in Breast Cancer
RASTER Five-Year Follow-Up Data Indicates Chemotherapy May Be Safely Withheld for Patients Deemed ‘Low Risk’ for Breast Cancer Recurrence Using Agendia’s MammaPrint Test, Data Presented at European Breast Cancer Conference IRVINE, CA and AMSTERDAM, THE Read More
Agendia Wins 2011 Scrip Award for “Best Partnership Alliance”
IRVINE, CA and AMSTERDAM, THE NETHERLANDS, FEBRUARY 29, 2012 – Agendia, an innovative molecular cancer diagnostics company, today announced that the company is a recipient of the 2011 Scrip Award for “Best Partnership” for its Read More
Agendia Presents Broad Array of Predictive and Prognostic Studies on Breast and Colorectal Cancers at ASCO 2010 Annual Meeting
HUNTINGTON BEACH, CA, and AMSTERDAM, THE NETHERLANDS, June 4, 2010 -- Agendia, a world leader in molecular cancer diagnostics, today announced that researchers from Agendia and leading academic centers in the U.S. and Europe will present Read More